Volume 56, Issue 1

Estimation in a Cox Proportional Hazards Cure Model

Judy P. Sy

Biostatistics, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, U.S.A.

Search for more papers by this author
Jeremy M. G. Taylor

Department of Biostatistics, University of Michigan, Ann Arbor, Michigan 48109, U.S.A. email:jmgt@umich.edu

Search for more papers by this author
First published: 25 May 2004
Citations: 319

Abstract

Summary. Some failure time data come from a population that consists of some subjects who are susceptible to and others who are nonsusceptible to the event of interest. The data typically have heavy censoring at the end of the follow‐up period, and a standard survival analysis would not always be appropriate. In such situations where there is good scientific or empirical evidence of a nonsusceptible population, the mixture or cure model can be used (Farewell, 1982, Biometrics38, 1041–1046). It assumes a binary distribution to model the incidence probability and a parametric failure time distribution to model the latency. Kuk and Chen (1992, Biometrika79, 531–541) extended the model by using Cox's proportional hazards regression for the latency. We develop maximum likelihood techniques for the joint estimation of the incidence and latency regression parameters in this model using the nonparametric form of the likelihood and an EM algorithm. A zero‐tail constraint is used to reduce the near nonidentifiability of the problem. The inverse of the observed information matrix is used to compute the standard errors. A simulation study shows that the methods are competitive to the parametric methods under ideal conditions and are generally better when censoring from loss to follow‐up is heavy. The methods are applied to a data set of tonsil cancer patients treated with radiation therapy.

Number of times cited according to CrossRef: 319

  • Semiparametric estimation for proportional hazards mixture cure model allowing non-curable competing risk, Journal of Statistical Planning and Inference, 10.1016/j.jspi.2020.06.009, 211, (171-189), (2021).
  • A Mixture Model for Bivariate Interval-Censored Failure Times with Dependent Susceptibility, Statistics in Biosciences, 10.1007/s12561-020-09270-7, 12, 1, (37-62), (2020).
  • Treating non-responders: pitfalls and implications for cancer immunotherapy trial design, Journal of Hematology & Oncology, 10.1186/s13045-020-0847-x, 13, 1, (2020).
  • A bivariate joint frailty model with mixture framework for survival analysis of recurrent events with dependent censoring and cure fraction, Biometrics, 10.1111/biom.13202, 76, 3, (753-766), (2020).
  • Study design of single‐arm phase II immunotherapy trials with long‐term survivors and random delayed treatment effect, Pharmaceutical Statistics, 10.1002/pst.1976, 19, 4, (358-369), (2020).
  • Analysis of bivariate recurrent event data with zero inflation, Communications for Statistical Applications and Methods, 10.29220/CSAM.2020.27.1.037, 27, 1, (37-46), (2020).
  • A novel prognostic model based on multi‐omics features predicts the prognosis of colon cancer patients, Molecular Genetics & Genomic Medicine, 10.1002/mgg3.1255, 8, 7, (2020).
  • Nonparametric covariate hypothesis tests for the cure rate in mixture cure models, Statistics in Medicine, 10.1002/sim.8530, 39, 17, (2291-2307), (2020).
  • Bias in Mean Survival From Fitting Cure Models With Limited Follow-up, Value in Health, 10.1016/j.jval.2020.02.015, (2020).
  • LINKING ACCESS TO HEALTH OUTCOMES, Healthcare System Access, 10.1002/9781119601340, (99-135), (2020).
  • Review of current advances in survival analysis and frailty models, WIREs Computational Statistics , 10.1002/wics.1504, 12, 6, (2020).
  • Semiparametric estimation of the cure fraction in population‐based cancer survival analysis, Statistics in Medicine, 10.1002/sim.8693, 39, 26, (3787-3805), (2020).
  • The cure model in perinatal epidemiology, Statistical Methods in Medical Research, 10.1177/0962280220904092, (096228022090409), (2020).
  • Modeling and Analysis of Proportional Hazards Competing Risks Cure Rate Model, Journal of the Indian Society for Probability and Statistics, 10.1007/s41096-020-00076-w, (2020).
  • Stochastic EM algorithm for generalized exponential cure rate model and an empirical study, Journal of Applied Statistics, 10.1080/02664763.2020.1786676, (1-24), (2020).
  • A new non-linear conjugate gradient algorithm for destructive cure rate model and a simulation study: illustration with negative binomial competing risks, Communications in Statistics - Simulation and Computation, 10.1080/03610918.2020.1819321, (1-15), (2020).
  • Estimation in the Cox cure model with covariates missing not at random, with application to disease screening/prediction, Canadian Journal of Statistics, 10.1002/cjs.11550, 0, 0, (2020).
  • Bayesian cure fraction models with measurement error in the scale mixture of normal distribution, Statistical Methods in Medical Research, 10.1177/0962280219893034, (096228021989303), (2020).
  • EM algorithm for the additive risk mixture cure model with interval-censored data, Lifetime Data Analysis, 10.1007/s10985-020-09507-z, (2020).
  • Inclusion of time‐varying covariates in cure survival models with an application in fertility studies, Journal of the Royal Statistical Society: Series A (Statistics in Society), 10.1111/rssa.12501, 183, 1, (333-354), (2019).
  • Promoting sign consistency in the cure model estimation and selection, Statistical Methods in Medical Research, 10.1177/0962280218820356, 29, 1, (15-28), (2019).
  • Joint model for recurrent event data with a cured fraction and a terminal event, Biometrical Journal, 10.1002/bimj.201800321, 62, 1, (24-33), (2019).
  • A Prediction-Driven Mixture Cure Model and Its Application in Credit Scoring, European Journal of Operational Research, 10.1016/j.ejor.2019.01.072, (2019).
  • A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer, BMC Cancer, 10.1186/s12885-019-5346-5, 19, 1, (2019).
  • A Bayesian Piecewise Survival Cure Rate Model for Spatially Clustered Data, Spatial and Spatio-temporal Epidemiology, 10.1016/j.sste.2019.02.001, (2019).
  • Hazard-Based Duration Models for Predicting Actual Duration of Highway Projects Using Nonparametric and Parametric Survival Analysis, Journal of Management in Engineering, 10.1061/(ASCE)ME.1943-5479.0000700, 35, 6, (04019024), (2019).
  • Cox regression of clustered event times with covariates missing not at random, Scandinavian Journal of Statistics, 10.1111/sjos.12409, 46, 4, (1315-1346), (2019).
  • Score tests based on a finite mixture model of Markov processes under intermittent observation, Statistics in Medicine, 10.1002/sim.8155, 38, 16, (3013-3025), (2019).
  • Analysis of clustered failure time data with cure fraction using copula, Statistics in Medicine, 10.1002/sim.8213, 38, 21, (3961-3973), (2019).
  • Sequential imputation for models with latent variables assuming latent ignorability, Australian & New Zealand Journal of Statistics, 10.1111/anzs.12264, 61, 2, (213-233), (2019).
  • The single‐index/Cox mixture cure model, Biometrics, 10.1111/biom.12999, 75, 2, (452-462), (2019).
  • Variable selection and nonlinear effect discovery in partially linear mixture cure rate models, Biostatistics & Epidemiology, 10.1080/24709360.2019.1663665, 3, 1, (156-177), (2019).
  • Connections between cure rates and survival probabilities in proportional hazards models, Stat, 10.1002/sta4.255, 8, 1, (2019).
  • A new mixture cure model under competing risks to score online consumer loans, Quantitative Finance, 10.1080/14697688.2018.1552791, (1-11), (2019).
  • Optimizing predictive performance of criminal recidivism models using registration data with binary and survival outcomes, PLOS ONE, 10.1371/journal.pone.0213245, 14, 3, (e0213245), (2019).
  • Semiparametric estimation for accelerated failure time mixture cure model allowing non-curable competing risk, Statistical Theory and Related Fields, 10.1080/24754269.2019.1600123, (1-12), (2019).
  • Destructive cure rate models under proportional odds and associated likelihood inference, Communications in Statistics: Case Studies, Data Analysis and Applications, 10.1080/23737484.2019.1605632, (1-42), (2019).
  • Joint longitudinal and time-to-event cure models for the assessment of being cured, Statistical Methods in Medical Research, 10.1177/0962280219853599, (096228021985359), (2019).
  • Mixture cure models with time-varying and multilevel frailties for recurrent event data, Statistical Methods in Medical Research, 10.1177/0962280219859377, (096228021985937), (2019).
  • Marginal regression of recurrent gap times based on semiparametric transformation cure model, Communications in Statistics - Simulation and Computation, 10.1080/03610918.2019.1583343, (1-15), (2019).
  • Asymptotic distribution theory on pseudo semiparametric maximum likelihood estimator with covariates missing not at random, Communications in Statistics - Theory and Methods, 10.1080/03610926.2019.1678639, (1-12), (2019).
  • A support vector machine based semiparametric mixture cure model, Computational Statistics, 10.1007/s00180-019-00931-w, (2019).
  • Bayesian approach for proportional hazards mixture cure model allowing non-curable competing risk, Journal of Statistical Computation and Simulation, 10.1080/00949655.2019.1695798, (1-19), (2019).
  • The nonparametric location-scale mixture cure model, TEST, 10.1007/s11749-019-00698-8, (2019).
  • Semiparametric methods for survival data with measurement error under additive hazards cure rate models, Lifetime Data Analysis, 10.1007/s10985-019-09482-0, (2019).
  • Time-to-event analysis when the event is defined on a finite time interval, Statistical Methods in Medical Research, 10.1177/0962280219869364, (096228021986936), (2019).
  • Vertical modeling: analysis of competing risks data with a cure fraction, Lifetime Data Analysis, 10.1007/s10985-018-9417-8, 25, 1, (1-25), (2018).
  • A class of semiparametric cure models with current status data, Lifetime Data Analysis, 10.1007/s10985-018-9420-0, 25, 1, (26-51), (2018).
  • Sample size calculation for a proportional hazards mixture cure model with nonbinary covariates, Journal of Applied Statistics, 10.1080/02664763.2018.1498463, 46, 3, (468-483), (2018).
  • EM algorithms for fitting multistate cure models, Biostatistics, 10.1093/biostatistics/kxy011, 20, 3, (416-432), (2018).
  • Semiparametric sieve maximum likelihood estimation under cure model with partly interval censored and left truncated data for application to spontaneous abortion, Lifetime Data Analysis, 10.1007/s10985-018-9445-4, 25, 3, (507-528), (2018).
  • Semiparametric transformation models for interval‐censored data in the presence of a cure fraction, Biometrical Journal, 10.1002/bimj.201700304, 61, 1, (203-215), (2018).
  • Assessment of effect size and power for survival analysis through a binary surrogate endpoint in clinical trials, Statistics in Medicine, 10.1002/sim.7981, 38, 3, (301-314), (2018).
  • A utility‐based Bayesian phase I–II design for immunotherapy trials with progression‐free survival end point, Journal of the Royal Statistical Society: Series C (Applied Statistics), 10.1111/rssc.12288, 68, 2, (411-425), (2018).
  • Time Series Forecasting for Healthcare Diagnosis and Prognostics with the Focus on Cardiovascular Diseases, 6th International Conference on the Development of Biomedical Engineering in Vietnam (BME6), 10.1007/978-981-10-4361-1_138, (809-818), (2018).
  • Adaptive parametric prediction of event times in clinical trials, Clinical Trials, 10.1177/1740774517750633, 15, 2, (159-168), (2018).
  • A Novel behavioral scoring model for estimating probability of default over time in peer-to-peer lending, Electronic Commerce Research and Applications, 10.1016/j.elerap.2017.12.006, 27, (74-82), (2018).
  • Convergence properties of the EM algorithm in the mixture model with missing data, Journal of Physics: Conference Series, 10.1088/1742-6596/983/1/012091, 983, (012091), (2018).
  • geecure: An R-package for marginal proportional hazards mixture cure models, Computer Methods and Programs in Biomedicine, 10.1016/j.cmpb.2018.04.017, 161, (115-124), (2018).
  • Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?, Surgery, 10.1016/j.surg.2018.01.004, 163, 6, (1238-1244), (2018).
  • Cure Models in Survival Analysis, Annual Review of Statistics and Its Application, 10.1146/annurev-statistics-031017-100101, 5, 1, (311-342), (2018).
  • Modeling clustered long‐term survivors using marginal mixture cure model, Biometrical Journal, 10.1002/bimj.201700114, 60, 4, (780-796), (2018).
  • Joint modeling of recurrent events and a terminal event adjusted for zero inflation and a matched design, Statistics in Medicine, 10.1002/sim.7682, 37, 18, (2771-2786), (2018).
  • Weighted log‐rank test for time‐to‐event data in immunotherapy trials with random delayed treatment effect and cure rate, Pharmaceutical Statistics, 10.1002/pst.1878, 17, 5, (541-554), (2018).
  • Frailty Models and Frailty-Mixture Models for Recurrent Event Times, The Stata Journal: Promoting communications on statistics and Stata, 10.1177/1536867X1501500109, 15, 1, (135-154), (2018).
  • Goodness-of-fit tests for the cure rate in a mixture cure model, Biometrika, 10.1093/biomet/asy058, (2018).
  • Variable selection in proportional hazards cure model with time-varying covariates, application to US bank failures, Journal of Applied Statistics, 10.1080/02664763.2018.1554627, (1-21), (2018).
  • Negative Binomial Kumaraswamy-G Cure Rate Regression Model, Journal of Risk and Financial Management, 10.3390/jrfm11010006, 11, 1, (6), (2018).
  • Application of a Mixture Cure Fraction Model Based on the Generalized Modified Weibull Distribution for Analyzing Survival of Patients with Breast Cancer, International Journal of Cancer Management, 10.5812/ijcm.62863, 11, 5, (2018).
  • Macro-Economic Factors in Credit Risk Calculations: Including Time-Varying Covariates in Mixture Cure Models, Journal of Business & Economic Statistics, 10.1080/07350015.2016.1260471, 37, 1, (40-53), (2017).
  • A change-point model for detecting heterogeneity in ordered survival responses, Statistical Methods in Medical Research, 10.1177/0962280217707231, 27, 12, (3595-3611), (2017).
  • Gamma lifetimes and associated inference for interval-censored cure rate model with COM–Poisson competing cause, Communications in Statistics - Theory and Methods, 10.1080/03610926.2017.1321769, 47, 6, (1491-1509), (2017).
  • “Cure” Effects and Mortgage Default: A Split Population Survival Time Model, The Journal of Real Estate Finance and Economics, 10.1007/s11146-017-9597-0, 56, 2, (217-251), (2017).
  • Modeling Heterogeneity in Healthcare Utilization Using Massive Medical Claims Data, Journal of the American Statistical Association, 10.1080/01621459.2017.1330203, 113, 521, (111-121), (2017).
  • A weighted Poisson distribution and its application to cure rate models, Communications in Statistics - Theory and Methods, 10.1080/03610926.2017.1373817, 47, 17, (4297-4310), (2017).
  • A proportional hazard cure model for ordinal responses by self-modeling regression, Journal of Applied Statistics, 10.1080/02664763.2017.1410526, 45, 11, (2095-2106), (2017).
  • Mixture cure rate models with accelerated failures and nonparametric form of covariate effects, Journal of Nonparametric Statistics, 10.1080/10485252.2017.1404599, 30, 1, (216-237), (2017).
  • Semiparametric model and inference for spontaneous abortion data with a cured proportion and biased sampling, Biostatistics, 10.1093/biostatistics/kxx024, 19, 1, (54-70), (2017).
  • Concordance measure and discriminatory accuracy in transformation cure models, Biostatistics, 10.1093/biostatistics/kxx016, 19, 1, (14-26), (2017).
  • A Quasi‐Score Statistic for Homogeneity Testing against Covariate‐Varying Heterogeneity, Scandinavian Journal of Statistics, 10.1111/sjos.12308, 45, 3, (465-481), (2017).
  • A new extended Birnbaum-Saunders model with cure fraction: classical and Bayesian approach, Communications for Statistical Applications and Methods, 10.5351/CSAM.2017.24.4.397, 24, 4, (397-419), (2017).
  • Assessing the prediction accuracy of a cure model for censored survival data with long-term survivors: Application to breast cancer data, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2017.1293082, 27, 6, (918-932), (2017).
  • Proportional hazards under Conway–Maxwell-Poisson cure rate model and associated inference, Statistical Methods in Medical Research, 10.1177/0962280217708683, 26, 5, (2055-2077), (2017).
  • Mixture Cure Models in Prediction of Time to Default: Comparison with Logit and Cox Models, Contemporary Trends and Challenges in Finance, 10.1007/978-3-319-54885-2_21, (221-231), (2017).
  • Landmark cure rate models with time-dependent covariates, Statistical Methods in Medical Research, 10.1177/0962280217708681, 26, 5, (2042-2054), (2017).
  • Cure modeling in real-time prediction: How much does it help?, Contemporary Clinical Trials, 10.1016/j.cct.2017.05.012, 59, (30-37), (2017).
  • On the likelihood of mixture cure models, Statistics & Probability Letters, 10.1016/j.spl.2017.08.006, 131, (51-55), (2017).
  • Nonparametric incidence estimation and bootstrap bandwidth selection in mixture cure models, Computational Statistics & Data Analysis, 10.1016/j.csda.2016.08.002, 105, (144-165), (2017).
  • Accounting for Cured Patients in Cost-Effectiveness Analysis, Value in Health, 10.1016/j.jval.2016.04.011, 20, 4, (705-709), (2017).
  • Time to default in credit scoring using survival analysis: a benchmark study, Journal of the Operational Research Society, 10.1057/s41274-016-0128-9, 68, 6, (652-665), (2017).
  • A new class of defective models based on the Marshall–Olkin family of distributions for cure rate modeling, Computational Statistics & Data Analysis, 10.1016/j.csda.2016.10.001, 107, (48-63), (2017).
  • Prediction accuracy for the cure probabilities in mixture cure models, Statistical Methods in Medical Research, 10.1177/0962280217708673, 26, 5, (2029-2041), (2017).
  • Cure-Rate Survival Models and Their Application to Cancer Clinical Trials, Frontiers of Biostatistical Methods and Applications in Clinical Oncology, 10.1007/978-981-10-0126-0, (165-178), (2017).
  • L0 Regularization for the Estimation of Piecewise Constant Hazard Rates in Survival Analysis, Applied Mathematics, 10.4236/am.2017.83031, 08, 03, (377-394), (2017).
  • A flexible family of transformation cure rate models, Statistics in Medicine, 10.1002/sim.7293, 36, 16, (2559-2575), (2017).
  • Inference in a survival cure model with mismeasured covariates using a simulation-extrapolation approach, Biometrika, 10.1093/biomet/asw054, (asw054), (2017).
  • Computationally Efficient Estimation for the Generalized Odds Rate Mixture Cure Model with Interval Censored Data, Journal of Computational and Graphical Statistics, 10.1080/10618600.2017.1349665, (0-0), (2017).
  • Variable selection for mixture and promotion time cure rate models, Statistical Methods in Medical Research, 10.1177/0962280216677748, 27, 7, (2185-2199), (2016).
  • Diagnostic checks in mixture cure models with interval-censoring, Statistical Methods in Medical Research, 10.1177/0962280216676502, 27, 7, (2114-2131), (2016).
  • Nonparametric latency estimation for mixture cure models, TEST, 10.1007/s11749-016-0515-1, 26, 2, (353-376), (2016).
  • See more

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.